PACS Group (PACS) Stock Price, News & Analysis

Company Overview

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Key Stats

• Today's Range: $32.36 to $33.48
• 50-Day Range: $30.31 to $41.60
• 52-Week Range: $7.50 to $43.08
• Volume: 320,030 shs
• Average Volume: 924,213 shs
• Market Capitalization: $5.12 billion
• P/E Ratio: 26.51
• Dividend Yield: N/A
• Price Target: $44.40
• Consensus Rating: Buy

PACS Group Stock Analysis - MarketRank™

PACS Group scored higher than 87% of companies evaluated by MarketBeat, and ranked 78th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.5 / 5
• Analyst Rating: Buy

Consensus Rating

PACS Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 4 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

PACS Group has a consensus price target of $44.40, representing about 36.2% upside from its current price of $32.61.

Amount of Analyst Coverage

PACS Group has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 11.42%

Earnings Growth

Earnings for PACS Group are expected to grow by 11.42% in the coming year, from $2.19 to $2.44 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of PACS Group is 26.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.55.

Price to Earnings Ratio vs. Sector

The P/E ratio of PACS Group is 26.51, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.03.

Price to Earnings Growth Ratio

PACS Group has a PEG Ratio of 1.01. PEG Ratios around 1 indicate that a company is correctly valued.

Price to Book Value per Share Ratio

PACS Group has a P/B Ratio of 5.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.49% of the float of PACS Group has been sold short.

Short Interest Ratio / Days to Cover

PACS Group has a short interest ratio ("days to cover") of 6.49.

Change versus previous month

Short interest in PACS Group has recently increased by 3.81%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

PACS Group does not currently pay a dividend.

Dividend Growth

PACS Group does not have a long track record of dividend growth.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.39

News Sentiment

PACS Group has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for PACS Group this week, compared to 3 articles on an average week.

Search Interest

Only 1 people have searched for PACS on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

MarketBeat Follows

4 people have added PACS Group to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, PACS Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,245,564.00 in company stock.

Percentage Held by Insiders

70.40% of the stock of PACS Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

PACS Group has minimal institutional ownership at this time.

PACS Stock Analysis - Frequently Asked Questions

How have PACS shares performed this year?

PACS Group's stock was trading at $38.28 at the beginning of the year. Since then, PACS stock has decreased by 14.8% and is now trading at $32.6080.

How were PACS Group's earnings last quarter?

PACS Group, Inc. (NYSE:PACS) posted its earnings results on Wednesday, November, 19th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.46 by $0.36. The firm earned $1.03 billion during the quarter, compared to the consensus estimate of $1.11 billion. PACS Group had a trailing twelve-month return on equity of 22.55% and a net margin of 3.62%.

When did PACS Group IPO?

PACS Group (PACS) raised $450 million in an initial public offering (IPO) on Thursday, April 11th 2024. The company issued 21,428,572 shares at a price of $20.00-$22.00 per share.

Who are PACS Group's major shareholders?

Top institutional shareholders of PACS Group include BI Asset Management Fondsmaeglerselskab A S (0.13%), Bank of New York Mellon Corp (0.11%), Principal Financial Group Inc. (0.06%) and Peterson Wealth Services (0.03%). Insiders that own company stock include Jason Hulse Murray, Joshua Jergensen, John Todd Mitchell, Evelyn S Dilsaver and Jacqueline Millard.
View institutional ownership trends.

How do I buy shares of PACS Group?

Shares of PACS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of PACS Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PACS Group investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Visa (V).

Company Calendar

• Last Earnings: 11/19/2025
• Today: 5/05/2026
• Next Earnings (Estimated): 5/07/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSE:PACS
• Previous Symbol: NYSE:PACS
• CIK: 2001184
• Web: pacs.com
• Phone: 801-447-9829
• Fax: N/A
• Employees: 47,455
• Year Founded: N/A

Price Target and Rating

• Average Price Target for PACS Group: $44.40
• High Price Target: $52.00
• Low Price Target: $40.00
• Potential Upside/Downside: +36.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.23
• Trailing P/E Ratio: 26.51
• Forward P/E Ratio: 14.89
• P/E Growth: 1.01
• Net Income: $191.54 million
• Net Margins: 3.62%
• Pretax Margin: 5.38%
• Return on Equity: 22.55%
• Return on Assets: 3.45%

Debt

• Debt-to-Equity Ratio: 0.36
• Current Ratio: 1.07
• Quick Ratio: 1.07

Sales & Book Value

• Annual Sales: $5.29 billion
• Price / Sales: 0.97
• Cash Flow: $1.58 per share
• Price / Cash Flow: 20.64
• Book Value: $6.08 per share
• Price / Book: 5.36

Miscellaneous

• Outstanding Shares: 157,165,000
• Free Float: 46,521,000
• Market Cap: $5.12 billion
• Optionable: Optionable
• Beta: -0.03